Stock Price Forecast

Jan. 9, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading AIkido Pharma Inc chart...

About the Company

AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, we are constantly seeking to grow our pipeline to treat unmet medical needs in oncology. The Company is also developing a broad-spectrum antiviral platform that may potentially inhibit replication of multiple viruses including Influenza virus, SARS-CoV (coronavirus), MERS-CoV, Ebolavirus and Marburg virus.

CEO

Anthony Hayes

Exchange

NASDAQ

Website

aikidopharma.com

$0M

Total Revenue

5

Employees

$18M

Market Capitalization

-1.49

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AIKI News

Athira Pharma Inc Ordinary Shares ATHA

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

11 Best Small Cap Pharma Stocks to Invest In

24d ago, source: Insider Monkey

For pharma stocks, these can be either big ticket and stable names such as Pfizer Inc. (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ) can leverage markets for developed pharmaceutical products ...

ACST Acasti Pharma Inc.

13d ago, source: Seeking Alpha

Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company’s lead product candidate is the GTX-104 ...

MEI Pharma Inc.

1d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Kokikai Aikido

9y ago, source: Princeton University

An effective form of self-defense, Kokikai Aikido relies on a strong mind and correct technique not physical strength alone. As a result classes include both men and women practicing on equal footing.

Acasti Pharma Inc. Class A

5y ago, source: CNN

Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases.

Vincerx Pharma Inc Ordinary Shares VINC

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Q4 2023 Evoke Pharma Inc Earnings Call

13d ago, source: Yahoo Finance

Matthew D’Onofrio; President and Chief Operations Officer; Evoke Pharma Inc Yale Jen; Analyst; Laidlaw & Company Operator Good afternoon and welcome to the Evoke Pharma fourth-quarter and full ...

ESSA Pharma Inc

1mon ago, source: CNN

ESSA Pharma, Inc. is a clinical stage pharmaceutical company. It engages in the business of developing small molecule drugs for the treatment of prostate cancer. The company was founded by Marianne D.

LUMO Lumos Pharma, Inc.

6d ago, source: Seeking Alpha

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its primary product candidate LUM-201 is an oral ...

Acasti Pharma Inc. Class A

3y ago, source: CNN

Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases.

Vincerx Pharma, Inc. (VINC)

8d ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...